Wnt pathway antagonists, SFRP1, SFRP2, SOX17, and PPP2R2B, are methylated in gliomas and SFRP1 methylation predicts shorter survival
Crossref DOI link: https://doi.org/10.1007/s13353-015-0312-7
Published Online: 2015-09-04
Published Print: 2016-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Majchrzak-Celińska, Aleksandra
Słocińska, Marta
Barciszewska, Anna-Maria
Nowak, Stanisław
Baer-Dubowska, Wanda
License valid from 2015-09-04